Advertisement

Clinical Oral Investigations

, Volume 10, Issue 4, pp 261–268 | Cite as

How may stressful experiences contribute to the development of temporomandibular disorders?

  • Gustavo Hauber GameiroEmail author
  • Annicele da Silva Andrade
  • Darcy Flávio Nouer
  • Maria Cecília Ferraz de Arruda Veiga
Review

Abstract

Temporomandibular disorders (TMD) comprise the most common cause of chronic facial pain conditions, and they are often associated with somatic and psychological complaints including fatigue, sleep disturbances, anxiety, and depression. For many health professionals, the subjectivity of pain experience is frequently neglected even when the clinic does not find any plausible biologic explanation for the pain. This strictly biomedical vision of pain cannot be justified scientifically. The purpose of this study is to demonstrate, by original articles from the literature and recent studies conducted in our own laboratory, the biological processes by which psychological stress can be translated into the sensation of pain and contribute to the development of TMD. The role of the hypothalamic–pituitary–adrenal axis, the serotoninergic and opioid systems in the pathogenesis of facial pain is exposed, including possible future therapeutic approaches. It is hoped that knowledge from apparently disparate fields of dentistry, integrated into a multidisciplinary clinical approach to TMD, will improve diagnosis and treatment for this condition through a clinical practice supported by scientific knowledge.

Keywords

Stress Pain Temporomandibular disorders Nociception Temporomandibular joint 

Notes

Acknowledgements

The authors had the following contributions in the completion of this manuscript: Gustavo Hauber Gameiro (Doctor in Physiology/Faculty of Dentistry of Piracicaba, University of Campinas)—literature review, data organization, and technical assistance; Annicele da Silva Andrade (Post-Graduation Student/Faculty of Dentistry of Piracicaba, University of Campinas)—literature review and manuscript preparation; Darcy Flávio Nouer (Doctor in Orthodontics/Faculty of Dentistry of Piracicaba, University of Campinas)—literature review and data organization; and Maria Cecília Ferraz de Arruda Veiga (Doctor in Physiology/Faculty of Dentistry of Piracicaba, University of Campinas)—literature review, data organization, and statistical analysis.

References

  1. 1.
    Adell A, Casanovas JM, Artigas F (1997) Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 36:735–741PubMedCrossRefGoogle Scholar
  2. 2.
    Ahlberg K, Ahlberg J, Kononen M, Alakuijala A, Partinen M, Savolainen A (2005) Perceived orofacial pain and its associations with reported bruxism and insomnia symptoms in media personnel with or without irregular shift work. Acta Odontol Scand 63:213–217PubMedCrossRefGoogle Scholar
  3. 3.
    Auvenshine RC (1997) Psychoneuroimmunology and its relationship to the differential diagnosis of temporomandibular disorders. Dent Clin North Am 41:279–296PubMedGoogle Scholar
  4. 4.
    Bereiter DA (2001) Sex differences in brainstem neural activation after injury to the TMJ region. Cells Tissues Organs 169:226–237PubMedCrossRefGoogle Scholar
  5. 5.
    Bernini GP, Argenio GF, Vivaldi MS, Del Corso C, Sgro M, Franchi F, Luisi M (1989) Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system. Horm Res 3:133–137CrossRefGoogle Scholar
  6. 6.
    Bodnar RJ, Klein GE (2004) Endogenous opiates and behavior: 2003. Peptides 25:2205–2256PubMedCrossRefGoogle Scholar
  7. 7.
    Bonjardim LR, Gaviao MB, Pereira LJ, Castelo PM (2005) Anxiety and depression in adolescents and their relationship with signs and symptoms of temporomandibular disorders. Int J Prosthodont 18:347–352PubMedGoogle Scholar
  8. 8.
    Carlsson GE (1999) Epidemiology and treatment need for temporomandibular disorders. J Orofac Pain 13:232–237PubMedGoogle Scholar
  9. 9.
    Christensen L (1975) Some effects of experimental hyperactivity of the mandibular locomotor system in man. J Oral Rehabil 2:169–178Google Scholar
  10. 10.
    Chrousos GP (1998) Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci 851:311–335PubMedCrossRefGoogle Scholar
  11. 11.
    Chrousos GP, Gold PW (1992) The concepts of stress and stress system disorders. Overview of physical and behavioural homeostasis. JAMA 267:1244–1252. Erratum in: JAMA (1992) 268:200PubMedCrossRefGoogle Scholar
  12. 12.
    Chrousos GP, Loriaux DL, Gold PW (1988) Advances in experimental medicine and biology, vol 245. Mechanisms of physical and emotional stress. Plenum, New YorkGoogle Scholar
  13. 13.
    Clark GT, Adler RC (1985) A critical evaluation of occlusal therapy: occlusal adjustment procedures. J Am Dent Assoc 110:743–750PubMedGoogle Scholar
  14. 14.
    Contoreggi C, Rice KC, Chrousos G (2004) Nonpeptide corticotropin-releasing hormone receptor type 1 antagonists and their applications in psychosomatic disorders. Neuroendocrinology 80:111–123PubMedCrossRefGoogle Scholar
  15. 15.
    De Leeuw JR, Steenks MH, Ros WJ, Lobbezoo-Scholte AM, Bosman F, Winnubst JA (1994) Multidimensional evaluation of craniomandibular dysfunction. I: symptoms and correlates. J Oral Rehabil 21:501–514PubMedGoogle Scholar
  16. 16.
    Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW (1991) Evidence for impaired activation of the hypothalamic–pituitary–adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 73:1224–1234PubMedGoogle Scholar
  17. 17.
    Drolet G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF (2001) Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25:729–741PubMedCrossRefGoogle Scholar
  18. 18.
    Dworkin SF, Huggins KH, LeResche L, Von Korff M, Howard J, Truelove E, Sommers E (1990) Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls. J Am Dent Assoc 120:273–281PubMedGoogle Scholar
  19. 19.
    Feinmann C (1983) Psychogenic facial pain: presentation and treatment. J Psychosom Res 27:403–410PubMedCrossRefGoogle Scholar
  20. 20.
    Feinmann C (1999) The mouth, the face and the mind. Oxford University Press, OxfordGoogle Scholar
  21. 21.
    Ferrier IN (1994) Disturbed hypothalamic–pituitary–adrenal axis regulation in depression: causes and consequences. In: Montgomery SA, Corn TH (eds) Psychopharmacology of depression. Oxford University Press, New York, pp 47–56Google Scholar
  22. 22.
    Fricton JR (1999) Masticatory myofascial pain: an explanatory model integrating clinical, epidemiological and basic science research. Bull Group Int Rech Sci Stomatol Odontol 41:14–25PubMedGoogle Scholar
  23. 23.
    Fujii T, Torisu T, Nakamura S (2005) A change of occlusal conditions after splint therapy for bruxers with and without pain in the masticatory muscles. Cranio 23:113–118PubMedGoogle Scholar
  24. 24.
    Gameiro GH, Arthuri MT, Tambeli CH, Veiga MCFA (2003) Effects of ethanol on deep pain evoked by formalin injected in TMJ of rat. Life Sci 73:3351–3361PubMedCrossRefGoogle Scholar
  25. 25.
    Gameiro GH, Andrade Ada S, de Castro M, Pereira LF, Tambeli CH, Veiga MC (2005) The effects of restraint stress on nociceptive responses induced by formalin injected in rat’s TMJ. Pharmacol Biochem Behav 82:338–344PubMedGoogle Scholar
  26. 26.
    Gameiro GH, Gameiro PH, Andrade AS, Arthuri MT, Pereira LF, Marcondes FK, Veiga MCFA (2006) Nociception- and anxiety-like behavior in rats submitted to different periods of restraint stress. Physiol Behav 87:643–649PubMedCrossRefGoogle Scholar
  27. 27.
    Geissler PR (1985) An investigation of the stress factor in the mandibular dysfunction syndrome. J Dent 13:283–287PubMedCrossRefGoogle Scholar
  28. 28.
    Gerber PE, Lynd LD (1998) Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother 32:692–698PubMedCrossRefGoogle Scholar
  29. 29.
    Glaros AG, Burton E (2004) Parafunctional clenching, pain, and effort in temporomandibular disorders. J Behav Med 27:91–100PubMedCrossRefGoogle Scholar
  30. 30.
    Gold PW, Chrousos GP (1999) The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians 111:22–34PubMedCrossRefGoogle Scholar
  31. 31.
    Gold PW, Pigott TA, Kling MK, Kalogeras K, Chrousos GP (1988) Basic and clinical studies with corticotropin releasing hormone: implications for a possible role in panic disorder. Psychiatr Clin North Am 11:327PubMedGoogle Scholar
  32. 32.
    Griep EN, Boersma JW, de Kloet ER (1993) Altered reactivity of the hypothalamic–pituitary–adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20:469–474PubMedGoogle Scholar
  33. 33.
    Grzesiak RC (1991) Psychologic consideration in temporomandibular dysfunction. A biopsychosocial view of symptom formation. Dent Clin North Am 35:209–226PubMedGoogle Scholar
  34. 34.
    Habib KE, Gold PW, Chrousos GP (2001) Neuroendocrinology of stress. Endocrinol Metab Clin North Am 30:695–728PubMedCrossRefGoogle Scholar
  35. 35.
    Held K, Kunzel H, Ising M, Schmid DA, Zobel A, Murck H, Holsboer F, Steiger A (2004) Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression. J Psychiatr Res 38:129–136PubMedCrossRefGoogle Scholar
  36. 36.
    Herman JP, Cullinan WE (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary–adrenocortical axis. Trends Neurosci 20:78–84PubMedCrossRefGoogle Scholar
  37. 37.
    Insel TR, Kalin NH, Guttmacher LB, Cohen RM, Murphy DL (1982) The dexamethasone suppression test in patients with primary obsessive-compulsive disorder. Psychiatry Res 6:153–160PubMedCrossRefGoogle Scholar
  38. 38.
    Kapel L, Glaros AG, McGlynn FD (1989) Psychophysiological responses to stress in patients with myofascial pain-dysfunction syndrome. J Behav Med 12:397–406PubMedCrossRefGoogle Scholar
  39. 39.
    Karibe H, Goddard G, Gear RW (2003) Sex differences in masticatory muscle pain after chewing. J Dent Res 82:112–116PubMedGoogle Scholar
  40. 40.
    Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW (1987) Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab 64:203–208PubMedGoogle Scholar
  41. 41.
    Kirby LG, Allen AR, Lucki I (1995) Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid. Brain Res 682:189–196PubMedCrossRefGoogle Scholar
  42. 42.
    Klerman EB, Goldenberg DL, Brown EN, Maliszewski AM, Adler GK (2001) Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab 86:1034–1039PubMedCrossRefGoogle Scholar
  43. 43.
    Koh H, Robinson PG (2004) Occlusal adjustment for treating and preventing temporomandibular joint disorders. J Oral Rehabil 31:287–292PubMedGoogle Scholar
  44. 44.
    Korszun A, Hinderstein B, Wong M (1996) Comorbidity of depression with chronic facial pain and temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:496–500PubMedCrossRefGoogle Scholar
  45. 45.
    Korszun A, Young EA, Singer K, Carlson NE, Brown MB, Crofford L (2002) Basal circadian cortisol secretion in women with temporomandibular disorders. J Dent Res 81:279–283PubMedCrossRefGoogle Scholar
  46. 46.
    Kunzel HE, Ising M, Zobel AW, Nickel T, Ackl N, Sonntag A, Holsboer F, Uhr M (2005) Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression. J Psychiatr Res 39:173–177PubMedCrossRefGoogle Scholar
  47. 47.
    Kuttila M, Niemi PM, Kuttila S, Alanen P, Le Bell Y (1998) TMD treatment need in relation to age, gender, stress, and diagnostic subgroup. J Orofac Pain 12:67–74PubMedGoogle Scholar
  48. 48.
    Lariviere WR, Melzack R (2000) The role of corticotropin-releasing factor in pain and analgesia. Pain 84:1–12PubMedCrossRefGoogle Scholar
  49. 49.
    Laskin DM (1969) Etiology of the pain-dysfunction syndrome. J Am Dent Assoc 79:147–153PubMedGoogle Scholar
  50. 50.
    Lavigne GJ, Kato T, Kolta A, Sessle BJ (2003) Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med 14:30–46PubMedCrossRefGoogle Scholar
  51. 51.
    LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF (2003) Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 106:253–261PubMedCrossRefGoogle Scholar
  52. 52.
    Macfarlane TV, Blinkhorn AS, Davies RM, Kincey J, Worthington HV (2002) Oro-facial pain in the community: prevalence and associated impact. Community Dent Oral Epidemiol 30:52–60PubMedCrossRefGoogle Scholar
  53. 53.
    Magnusson T, Egermark I, Carlsson GE (2000) A longitudinal epidemiologic study of signs and symptoms of temporomandibular disorders from 15 to 35 years of age. J Orofac Pain 14:310–319PubMedGoogle Scholar
  54. 54.
    Magnusson T, Egermarki I, Carlsson GE (2005) A prospective investigation over two decades on signs and symptoms of temporomandibular disorders and associated variables. A final summary. Acta Odontol Scand 63:99–109PubMedGoogle Scholar
  55. 55.
    Maier SF, Watkins LR, Fleshner M (1994) Psychoneuroimmunology. The interface between behavior, brain, and immunity. Am Psychol 49:1004–1017PubMedCrossRefGoogle Scholar
  56. 56.
    Maixner W, Gracely RH, Zuniga JR, Humphrey CB, Bloodworth GR (1990) Cardiovascular and sensory responses to forearm ischemia and dynamic hand exercise. Am J Physiol 259:R1156–R1163PubMedGoogle Scholar
  57. 57.
    Marbach JJ, Schleifer SJ, Keller SE (1990) Facial pain, distress, and immune function. Brain Behav Immun 4:243–254PubMedCrossRefGoogle Scholar
  58. 58.
    Mason P, Gao K (1998) Raphe magnus serotoninergic neurons tonically modulate nociceptive transmission. Pain Forum 7:143–150Google Scholar
  59. 59.
    McQuade R, Young AH (2000) Future therapeutic targets in mood disorders: the glucocorticoid receptor. Br J Psychiatry 177:390–395PubMedCrossRefGoogle Scholar
  60. 60.
    Melzack R (1999) From the gate to the neuromatrix. Pain Suppl 6:S121–S126CrossRefGoogle Scholar
  61. 61.
    Mercuri LG, Olson RE, Laskin DM (1979) The specificity of response to experimental stress in patients with myofascial pain dysfunction syndrome. J Dent Res 58:1866–1871PubMedGoogle Scholar
  62. 62.
    Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355–474PubMedCrossRefGoogle Scholar
  63. 63.
    Miller VJ, Karic VV, Myers SL, Bodner L (2003) Following treatment of myogenous TMD patients with the temporomandibular opening index: an initial report. J Oral Rehabil 30:668–670PubMedCrossRefGoogle Scholar
  64. 64.
    Mohlin BO, Derweduwen K, Pilley R, Kingdon A, Shaw WC, Kenealy P (2004) Malocclusion and temporomandibular disorder: a comparison of adolescents with moderate to severe dysfunction with those without signs and symptoms of temporomandibular disorder and their further development to 30 years of age. Angle Orthod 74:319–327PubMedGoogle Scholar
  65. 65.
    Moss RA, Adams HE (1984) Physiological reactions to stress in subjects with and without myofascial pain dysfunction symptoms. J Oral Rehabil 11:219–232PubMedGoogle Scholar
  66. 66.
    Moss RA, Ruff MH, Sturgis ET (1984) Oral behavioural patterns in facial pain, headache and non-headache populations. Behav Res Ther 22:683–687PubMedCrossRefGoogle Scholar
  67. 67.
    Okeson JP (1996) In: Okeson JP (ed) Orofacial pain, guidelines for assessment, diagnosis, and management. Quintessence Publishing, Carol Stream, IllinoisGoogle Scholar
  68. 68.
    Pacak K, Palkovits M (2001) Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 22:502–548PubMedCrossRefGoogle Scholar
  69. 69.
    Palermo TM, Drotar D (1996) Prediction of children’s postoperative pain: the role of pre-surgical expectations and anticipatory emotions. J Pediatr Psychol 21:683–698PubMedGoogle Scholar
  70. 70.
    Passchier J, Verheij R, Tulen JH, Timmerman L, Pepplinkhuizen L (1992) Positive associations between anticipatory anxiety and needle pain for subjective but not for physiological measures of anxiety. Psychol Rep 70:1059–1062PubMedCrossRefGoogle Scholar
  71. 71.
    Pergamalian A, Rudy TE, Zaki HS, Greco CM (2003) The association between wear facets, bruxism, and severity of facial pain in patients with temporomandibular disorders. J Prosthet Dent 90:194–200PubMedCrossRefGoogle Scholar
  72. 72.
    Roveroni RC, Parada CA, Cecilia M, Veiga FA, Tambeli CH (2001) Development of a behavioural model of TMJ pain in rats: the TMJ formalin test. Pain 94:185–191PubMedCrossRefGoogle Scholar
  73. 73.
    Rugh JD, Montgomery GT (1987) Physiological reactions of patients with TM disorders vs symptom-free controls on a physical stress task. J Craniomandib Disord 1:243–250PubMedGoogle Scholar
  74. 74.
    Rugh JD, Solberg WK (1976) Psychological implications in temporomandibular pain and dysfunction. Oral Sci Rev 7:3–30PubMedGoogle Scholar
  75. 75.
    Schreiber S, Vinokur S, Shavelzon V, Pick CG, Zahavi E, Shir Y (2001) A randomized trial of fluoxetine versus amitriptyline in musculo-skeletal pain. Isr J Psychiatry Relat Sci 38:88–94PubMedGoogle Scholar
  76. 76.
    Seligman DA, Pullinger AG (1991) The role of functional occlusal relationships in temporomandibular disorders: a review. J Craniomandib Disord 5:265–279PubMedGoogle Scholar
  77. 77.
    Selye H (1976) Stress in health and disease. Butterworths, BostonGoogle Scholar
  78. 78.
    Suvinen TI, Hanes KR, Gerschman JA, Reade PC (1997) Psychophysical subtypes of temporomandibular disorders. J Orofac Pain 11:200–205PubMedGoogle Scholar
  79. 79.
    Thilander B, Rubio G, Pena L, de Mayorga C (2002) Prevalence of temporomandibular dysfunction and its association with malocclusion in children and adolescents: an epidemiologic study related to specified stages of dental development. Angle Orthod 72:146–154PubMedGoogle Scholar
  80. 80.
    Vanderas AP (1994) Relationship between craniomandibular dysfunction and malocclusion in white children with and without unpleasant life events. J Oral Rehabil 21:177–183PubMedGoogle Scholar
  81. 81.
    Vanderpool J, Rosenthal N, Chrousos GP, Wher T, Gold PW (1991) Evidence for hypothalamic CRH deficiency in patients with seasonal affective disorder. J Clin Endocrinol Metab 72:1382–1387Google Scholar
  82. 82.
    Wand GS, Dobs AS (1991) Alterations in the hypothalamic–pituitary–adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab 72:1290–1295PubMedCrossRefGoogle Scholar
  83. 83.
    Wei F, Dubner R, Ren K (1999) Nucleus reticularis gigantocellularis and nucleus raphe magnus in the brain stem exert opposite effects on behavioural hyperalgesia and spinal Fos protein expression after peripheral inflammation. Pain 80:127–141. Erratum in: Pain (1999) 81:215–219PubMedCrossRefGoogle Scholar
  84. 84.
    Wei F, Dubner R, Ren K (1999) Laminar-selective noradrenergic and serotoninergic modulation includes spinoparabrachial cells after inflammation. Neuroreport 10:1757–1761PubMedCrossRefGoogle Scholar
  85. 85.
    Wexler GB, Steed PA (1998) Psychological factors and temporomandibular outcomes. Cranio 16:72–77PubMedGoogle Scholar
  86. 86.
    Yap AU, Dworkin SF, Chua EK, List T, Tan KB, Tan HH (2003) Prevalence of temporomandibular disorder subtypes, psychologic distress, and psychosocial dysfunction in Asian patients. J Orofac Pain 17:21–28PubMedGoogle Scholar
  87. 87.
    Yehuda R, Southwick SM, Nussbaum G, Wahby V, Giller EL Jr, Mason JW (1990) Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis 178:366–369PubMedCrossRefGoogle Scholar
  88. 88.
    Yemm R (1969) Temporomandibular dysfunction and masseter muscle response to experimental stress. Br Dent J 127:508–510PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Gustavo Hauber Gameiro
    • 1
    Email author
  • Annicele da Silva Andrade
    • 2
  • Darcy Flávio Nouer
    • 1
  • Maria Cecília Ferraz de Arruda Veiga
    • 2
  1. 1.Department of Orthodontics, Piracicaba Dental SchoolUniversity of Campinas—UnicampPiracicabaBrazil
  2. 2.Laboratory of Orofacial Pain, Department of Physiology, Piracicaba Dental SchoolUniversity of Campinas—UnicampPiracicabaBrazil

Personalised recommendations